Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: Radioligand binding studies

Molecular Pharmacology

Volumn 53, Issue 3, 1998, Pages 573-589

  Lazareno, S ^a   Gharagozloo, P ^a   Kuonen, D ^a   Popham, A ^a   Birdsall, N J M ^b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALKALOID DERIVATIVE; BRUCINE; BRUCINE DERIVATIVE; BRUCINE N OXIDE; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; N CHLOROMETHYLBRUCINE; STRYCHNINE; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CHO CELL; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL;

EID: 0031978756     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.3.573     Document Type: Article

References (39)

1. Birdsall NJM, Parries T, Gharagozloo P, Kobayashi S, Kuonen D, Lazareno S, Popham A, and Sugimoto M (1997) Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes. Life Sci 60:1047-1052.
2. Birdsall NJM and Hulme EC (1989) The binding properties of muscarinic receptors, in The Muscarinic Receptors (Brown JH, ed) pp 31-92, Humana Press, Clifton, NJ.
3. Birdsall NJM, Lazareno S, and Matsui H (1996) Allosteric regulation of muscarinic receptors. Prog Brain Res 109:147-151.
4. Caulfield MP (1993) Muscarinic receptors: characterization, coupling and function. Pharmacol Ther 58:319-379.
5. Colquhoun D (1971) Lectures on Biostatistics. Clarendon Press, Oxford, UK.
6. Ebihara S and Akaike N (1992) Strychnine-induced potassium current in CA1 pyramidal neurones of the rat hippocampus. Br J Pharmacol 106:823-827.
7. Ehlert FJ, Roeske WR, Gee KW, and Yamamura HI (1983) An allosteric model for benzodiazepine receptor function. Biochem Pharmacol 32:2375-2383.
8. Ehlert FJ, Roeske WR, and Yamamura HI (1994) Muscarinic receptors and novel strategies for the treatment of age-related brain disorders. Life Sci 55:2135-2145.
9. Ellis J and Seidenberg M (1992) Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol Pharmacol 42:638-641.
10. Farrington H, Mendelsohn F, Chan S, Reinlib L, and Guggino SE (1994) Strychnine-binding proteins in intestinal cells: novel brucine binding site with binding affinities for alkaloids. J Pharmacol Exp Ther 271:1074-1079.
11. 3H]acetylcholine to m2 muscarinic receptors. Biochem Pharmacol 52:1767-1775.
12. Hejnova L, Tucek S, and El-Fakahany EE (1995) Positive and negative allosteric interactions on muscarinic receptors. Eur J Pharmacol 291:427-430.
13. 2 dopamine receptors by amiloride and amiloride analogs. Mol Pharmacol 50:1295-1308.
14. Hollmann M and Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
15. Hulme EC, Birdsall NJM, and Buckley NJ (1990) Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 30:633-673.
16. Jakubik J, Bacakova L, El-Fakahany EE, and Tucek S (1997) Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Mol Pharmacol 52:172-179.
17. Jakubik J, Bacakova L, Lisa V, El-Fakahany EE, and Tucek S (1996) Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Proc Natl Acad Sci USA 93:8705-8709.
18. Kollias-Baker C, Ruble J, Dennis D, Bruns RF, Linden J, and Belardinelli L (1994) Allosteric enhancer PD 81,723 acts by novel mechanism to potentiate cardiac actions of adenosine. Circ Res 75:961-971.
19. Lazareno S and Birdsall NJM (1993) Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations. Br J Pharmacol 109:1110-1119.
20. Lazareno S and Birdsall NJM (1995) Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 48:362-378.
21. Lefkowitz RJ, Cotecchia S, Samama P, and Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-307.
22. A receptor channels. Annu Rev Neurosci 17:569-602.
23. Mackerer CR, Kochman RL, Shen TF, and Hershenson FM (1977) The binding of strychnine and strychnine analogs to synaptic membranes of rat brainstem and spinal cord. J Pharmacol Exp Ther 201:326-331.
24. Marvizon JCG, Vazquez J, Garcia Calvo M, Mayor FJ, Gomez AR, Valdivieso F, and Benavides J (1986) The glycine receptor: pharmacological studies and mathematical modeling of the allosteric interaction between the glycine- and strychnine-binding sites. Mol Pharmacol 30:590-597.
25. Mascia MP, Machu TK, and Harris RA (1996) Enhancement of homomeric glycine receptor function by long-chain alcohols and anaesthetics. Br J Pharmacol 119: 1331-1336.
26. 1B/1D receptors. Mol Pharmacol 50:752-762.
27. Matsui H, Lazareno S, and Birdsall NJM (1995) Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. Mol Pharmacol 47:88-98.
28. Minton AP and Sokolovsky M (1990) A model for the interaction of muscarinic receptors, agonists, and two distinct effector substances. Biochemistry 29:1586-1593.
29. + exchange. J Biol Chem 262:12387-12392.
30. 1 purinoceptors. Br J Pharmacol 119:1006-1012.
31. Proška J and Tuček S (1995) Competition between positive and negative allosteric effectors on muscarinic receptors. Mol Pharmacol 48:696-702.
32. Schrattenholz A, Pereira EF, Roth U, Weber KH, Albuquerque EX, and Maelicke A (1996) Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol Pharmacol 49:1-6.
33. 35S)TBPS binding. Brain Res 414:357-364.
34. 2 receptors. Mol Pharmacol 51:674-682.
35. Tuček S, Musilkova J, Nedoma J, Proška J, Shelkovnikov S, and Vorlicek J (1990) Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors. Mol Pharmacol 38:674-680.
36. Tuček S and Proška J (1995) Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol Sci 16:205-212.
37. Waelbroeck M (1994) Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors. Mol Pharmacol 46:685-692.
38. Waelbroeck M, Robberecht P, de-Neef P, and Christophe J (1988) Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine. J Recept Res 8:787-808.
39. Yeomans JS (1995) Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology 12:3-16.